The Daily Dose: Dueling DOACS
Your daily dose of the clinical news you may have missed.
We Can't Predict a COVID-19 Surge, But We Can Prepare Patients for It: AAFP Board Chair Dr Sterling Ransone, Jr
It is clear that COVID-19 comes in waves, but it's too soon in the life of the virus to predict patterns, Ransone says. Strategy? Get shots in arms.
Oral Superabsorbent Hydrogel May Help Prevent Progression of Prediabetes to Type 2 Diabetes: New Research
CMHC 2022. Post-hoc analysis of the LIGHT-UP study found GS200 significantly reduced postprandial insulin secretion in adults with overweight and prediabetes.
PCPs, Cardiologists May Not Adequately Stratify, Treat CV Risk in Patients with Type 2 Diabetes
CMHC. PCPs and cardiologists appeared to perform only half of items considered necessary for care of T2D patients in a new simulated patient study.
The Daily Dose: Insulin Rationing
Your daily dose of clinical news from Patient Care Online.
Drop in Vitamin D Implies Increased Cardiovascular Risk in T2D, According to New Research
CMHC 2022: A decrease in vitamin D levels is associated with increased cardiovascular risk in patients with type 2 diabetes, according to new study.
Apixaban Found More Effective than Rivaroxaban in Patients with AFib and Valvular Heart Disease
In the absence of randomized controlled head-to-head trials comparing the 2 anticoagulants, study authors say clinicians should consider their findings when choosing treatment.
How to Talk to Patients about Coadministration of Influenza and COVID-19 Vaccines This Year
AAFP Board Chair Sterling Ransone, Jr, MD, encourages patients to get both shots at one visit; if they don't, he has strategies to bring them back for the one they didn't get.
Insulin Rationing Common Among Adults with Diabetes, Likely to Avoid High Cost
Analysis of national health data found that 16.5% of all adult insulin users skipped doses in the past year.
The Daily Dose: More Readmissions in Women than Men after Myocardial Infarction
AAFP Tips on Getting Shots into Arms this Flu Season with Sterling Ransone, Jr, MD
AAFP Board Chair Sterling Ransone, Jr, MD, offers an Academy refresher on the annual push-back from patients that is so familiar to family medicine clinicians.
Tezepelumab Reduced Exacerbations in Severe, Uncontrolled Asthma, Regardless of Number of Additional Controller Medications
CHEST 2022. Tezepelumab significantly reduced AAER and improved lung function in patients taking 1, 2, or ≥3 long-acting β-agonists in addition to ICS.
Will This be the Year of the Twindemic? AAFP Board Chair Ransone Thinks Out Loud with Patient Care
About half of American adults plan not to get a flu shot this year; everyone is tired of COVID talk and prevention; but flu is brewing in the southern hemisphere, Ransone says.
More Readmissions in Women than Men after Acute Myocardial Infarction, New Study Finds
Findings underscore the need for ongoing efforts to improve prevention strategies, as CVD risk factors in younger women continue to rise, according to authors.
The Daily Dose: Adult RSV Vaccine
Early Diabetes Diagnosis in Women Associated with Early Age at Menopause in Large Canadian Cohort
Early age at either type 1 or type 2 diabetes diagnosis was associated with earlier age a menopause, suggesting an impact of diabetes on reproductive health, authors say.
The Daily Dose: CVD Risk Factors Linked to COVID-19 Death
AAFP Board Chair Sterling Ransone, Jr, MD, Has Concerns About Flu Season 2022-2023
Ransone hasn't had a case of influenza in his practice in 2 years, but with mitigation measures all but over and COVID-19 in the wings, this year could be different.
All Health Care Professionals Can Support One Another's Mental Health, Expert Says
Not every physician has to be a mental health expert to assist their colleagues, staff, and patients in improving their mental well-being. Just start the conversation.
GSK Announces Positive Pivotal Phase 3 Data for Adult RSV Vaccine Candidate
The investigational respiratory syncytial virus vaccine had an overall efficacy of 82.6% against RSV-LRTD, 94.6% against severe disease, and 94.1% in adults with comorbidities.
